Authors


Michaela Maher, PharmD Candidate

Latest:

The Fludarabine Shortage and Its Ripple Effects: Navigating the Crisis

The significant surge in oncology drug shortages in 2023 particularly affected essential chemotherapeutic drugs.


Elise Moore, PharmD Candidate

Latest:

Elevating the Therapeutic Relationship: The Future of Pharmacists in Outpatient Mental Health Services

Pharmacists working with patients with mental health conditions are able to optimize medication use and improve adherence.


Shelby Bennett, PharmD, BCACP

Latest:

5 Quick Tips to Create a Transformative Advanced Pharmacy Practice Experiences Rotation

What many preceptors may not realize is that in addition to learning about practice settings, all graduates of pharmacy schools in the United States must also be able to demonstrate leadership, innovation, and entrepreneurship.


Danielle K. Moorman

Latest:

Clinical Trials of Veterinary Medications Differ From Drugs for Human Use

FDA regulations under Food, Drug, and Cosmetic Act outline efficacy, safety requirements for animal pharmaceuticals.


Esther Banker, PharmD Candidate

Latest:

Student Pharmacists Can Play Important Role as Patient Advocates

Education and support inspire trust between patients and pharmacists.


David S. Taylor, PharmD, 340B ACE

Latest:

The Future of the 340B Drug Pricing Program in Modern Health Care

An examination of the 340B Drug Pricing Program's original intent, current challenges, and potential resolutions in today's complex health care landscape.


Ryan Davies

Latest:

Challenges and Opportunities in the Treatment of Ewing Sarcoma

Little progress has been made in developing treatments that can help to stop Ewing sarcomas from spreading or coming back.


Emilia Welch, PharmD, MBA

Latest:

Difficulty Administering OTC Acetaminophen and Ibuprofen in Children Leads to Dosing Errors

Community pharmacists have a unique opportunity to counsel caregivers on liquid OTC children’s products.


Sarah Carpio, BS

Latest:

Postpandemic Future Is Bright for Technicians

Tapping techs as immunizers opens up greater visibility and new source of health care labor.


Bryan Fitzgerald, PharmD, BCOP

Latest:

Trilaciclib Protects Against Chemotherapy-Induced Myelosuppression

Treatment's approval marks exciting new development for patients with ES-SCLC to prevent CIM.


Xiaoshan Chai, PharmD Candidate

Latest:

Adapting to the FDA's Phenylephrine Status Change in OTC Cold and Congestion Medications

Pharmacists' expertise is crucial in educating patients about regulatory changes, helping them navigate alternative formulations, and providing insights into evidence-based choices.


Syed Ahsan

Latest:

Catalyzing Commitment: The Symphony of AI-Powered Medication Adherence

Artificial intelligence–driven reminders empower patients, combating forgetfulness and enhancing treatment adherence for better health outcomes.


Justin (JC) Liauw, PharmD, BCOP

Latest:

Overview of PARP Inhibitors in the Treatment of Ovarian Cancer

There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.


Cameron Hammers, PharmD Candidate

Latest:

Case Report: Rivastigmine Overexposure Toxicities with Weight Loss

With gastrointestinal-based adverse effectss for rivastigmine and other cholinesterase inhibitors, a weight of <50 and <55 kg respectively leads to an increased risk for toxicities.


Christine Dimaculangan, PharmD, BCACP

Latest:

The Role of the Ambulatory Care Pharmacist in Promoting Vaccine Confidence

A pharmacist’s role in the ambulatory care setting has traditionally included a review of medications for potential drug-drug interactions and adverse events, medication reconciliation, and the provision of counseling services.


Scott Person, PharmD

Latest:

Overcharging Hospital Pharmacies: Unnecessary Hidden Costs

In hospital pharmacies, roughly 2% of pharmacy spend can be overcharge.


Catherine A. Koivisto, RPh

Latest:

The Expanding Role of Continuous Glucose Monitors in Pregnant Patients

The use of CGMs in pregnancy provides clinicians with essential data in real-time, rather than a snapshot given by traditional finger stick testing.


Nazeefa Tabassum, BPS, PharmD Candidate

Latest:

Zuranolone Offers An Innovative Treatment for Postpartum Depression

Zuranolone enhances health care providers’ ability to address the complex needs of patients with PPD, offering new hope for rapid and sustained relief from depressive symptoms.



Micaela Den Hartog, PharmD Candidate

Latest:

Let’s Not Sugar Coat It: HbA1c is the Imperfect Diabetes Diagnostic

When diabetes is uncontrolled, higher percentages of hemoglobin become glycated, which causes elevated HbA1c and glucose levels to rise within the body.


Alyson Houle

Latest:

Updated C. Difficile Infection Guidelines Incorporate New Trials

Infectious Disease Society of America and Society for Healthcare Epidemiology of America make 3 new treatment recommendations for adults.


Arsheeta Kumar, PharmD

Latest:

Pirtobrutinib and BTK Inhibitors in the CLL Treatment Landscape

This review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.


Hannah E. Moore

Latest:

Naloxone Training Requirements Vary Among States

New access laws allow pharmacists to establish standing orders with specific physicians or follow blanket, statewide protocols.


Gary Parker

Latest:

Pharma Moves Toward Value-Based Contracting

Part 1 of this 4-part series provides a general overview of the trends that are moving payers and pharmaceutical companies in this direction.


Pearl Steinzor

Latest:

Key Strategies Released for Integrating Equity Into Health Technology Assessment

The Center for Innovation & Value Research has released a final report recommending strategies to ensure health equity is integrated into health technology assessment, which can influence drug pricing and selection by payers, as well as patient access to drugs.


Cradesha Perry, PharmD, MBA

Latest:

Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK Inhibitors

This article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.


Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.


Ann Harty, AAHIVP, Fairview Health Service

Latest:

Health System-Based Specialty Pharmacy Offers Unique Advantages in HIV Care

Specialty pharmacists’ roles have grown in new and exciting ways in recent years, and those changes have directly impacted health outcomes for all specialty patients, including patients with HIV.


Sarah Visintainer, PharmD, BCGP, BCMTMS

Latest:

The Role of a Clinical Pharmacist in Melanoma Care and Education

Because of the likelihood that patients with melanoma will develop adverse effects on therapy, it is crucial for pharmacists to proactively educate patients and provide them with tools to help mitigate and manage these issues.


Mary Beth Seipel, PharmD, BCACP

Latest:

Overview of Nurtec ODT for Prevention of Episodic Migraine

Nurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.